Celcuity (CELC) Operating Leases (2019 - 2025)

Celcuity (CELC) reported Operating Leases of $54000.0 for Q4 2025, little changed on a YoY basis from $54000.0 in Q4 2024, and up 315.38% quarter-over-quarter from $13000.0 in Q1 2025.

Celcuity (CELC) Operating Leases (2019 - 2025) Analysis & Trends

Celcuity has reported Operating Leases for 7 years, with the latest figure at $54000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases changed 0.0% year-over-year to $54000.0; the trailing twelve-month figure through Dec 2025 stood at $54000.0 (changed 0.0% YoY), and the FY2025 full-year result was $54000.0, changed 0.0% from the prior year.
  • Operating Leases for Q4 2025 stood at $54000.0, up from $13000.0 in the prior quarter.
  • The five-year high for Operating Leases was $363961.0 in Q1 2023, with the low at $13000.0 in Q1 2025.
  • Historically, Operating Leases has averaged $131881.9 across 5 years, with a median of $107830.0 in 2022.
  • Annual changes were most pronounced in 2023 — Operating Leases jumped 2274.48% — and 2025, when it plunged 92.86%.
  • Celcuity's Operating Leases stood at $61771.0 in 2021, then retreated by 1.24% to $61002.0 in 2022, then surged by 270.35% to $225922.0 in 2023, then tumbled by 76.1% to $54000.0 in 2024, then changed by 0.0% to $54000.0 in 2025.
  • The last three Operating Leases figures came in at $54000.0 (Q4 2025), $13000.0 (Q1 2025), and $54000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Celcuity 4.14 Bn 3.42 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 95,699.00
Jun 30, 2024 138,533.00
Mar 31, 2024 182,079.00
Dec 31, 2023 225,922.00
Sep 30, 2023 270,925.00
Jun 30, 2023 317,120.00
Mar 31, 2023 363,961.00
Dec 31, 2022 61,002.00
Sep 30, 2022 107,830.00
Jun 30, 2022 156,769.00
Mar 31, 2022 15,328.00
Dec 31, 2021 61,771.00
Sep 30, 2021 108,915.00
Mar 31, 2021 15,139.00
Dec 31, 2020 53,000.00
Sep 30, 2020 107,040.00
Mar 31, 2020 176,600.00